Cargando…
Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention
Tumor immunotherapy brings substantial and long-term clinical benefits that can even cure tumors. However, the accumulation of evidence suggests that immunotherapy also induces severe and complex neurologic immune-related adverse events (ir-AEs) and even leads to immunotherapy-related death, which a...
Autores principales: | Zhang, Benxia, Li, Xue, Yin, Tao, Qin, Diyuan, Chen, Yue, Ma, Qizhi, Shu, Pei, Wang, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789457/ https://www.ncbi.nlm.nih.gov/pubmed/35087588 http://dx.doi.org/10.1155/2022/4259205 |
Ejemplares similares
-
Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor
por: Gao, Ge, et al.
Publicado: (2023) -
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021) -
Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models
por: Qin, Diyuan, et al.
Publicado: (2020) -
gC1qR: A New Target for Cancer Immunotherapy
por: Lei, Yanna, et al.
Publicado: (2023) -
Neurotoxicity of novel cancer immunotherapies
por: Willis, M. D., et al.
Publicado: (2019)